CNMD - CONMED Corp Debt to Book Capitalization Ratio

Corporate company logo of CONMED Corporation (CNMD)

CONMED Corporation (CNMD) maintains an impeccable reputation in orthopedic surgery, having earned physician trust through the quality of its products. The brand's steady revenue is driven by the sale of ancillary materials and the maintenance of monitoring systems. This price action for the securities on GURU.Markets, where the indicator stands at 0.77, is complemented by an environmental strategy focused on reducing emissions and recycling packaging during the production of medical devices.

CONMED Corporation - CNMD Debts to Book Capitalization (period 07/04/2022 - 10/29/2026)
Flagship merchandise of CONMED Inc.

To identify resilient assets, investors analyze financial leverage by assessing the proportion of borrowed funds relative to a company's equity. This debt-to-equity ratio for CONMED Corporation (CNMD) demonstrates how aggressively Curtis Hartman utilizes credit resources for expansion into orthopedics and gastroenterology, allowing for a balance between default risks and the efficiency of investments in innovative acquisitions.

Competitors of CONMED Corporation

DXCM: Debts to Book Capitalization|penumbrainc.com - Debts to Book Value|Debt to Book Capitalization Ratio Novanta (NOVT)|HAE - Debt to Net Assets Ratio|INSP: Debts to Book Capitalization|PRCT (Procept) - Debts to Book Capitalization|Debt to Book Capitalization Ratio Pulse Biosciences, Inc. PLSE|Debts to Book Capitalization Ratio inmodemd.com|Picard Medical - Debts to Book Capitalization|Debts to Book Value Surmodics Inc SRDX|Debt to Book Value SENS (senseonics.com)|NPCE - Debts to Book Capitalization|Debt to Book Value Tactile Systems Technology Inc. TCMD|SNWV - Debt to Book Capital|Outset Medical - Debts to Book Capitalization|Electromed (ELMD) - Debts to Net Assets|Debts to Book Capitalization LNSR|Debt to Book Value AVITA Medical Inc (RCEL)|Profound Medical Corp. (PROF) - Debt to Book Value|Debt to Net Assets Ratio BDMD (bairdmed.com)|EDAP TMS - Debt to Book Capitalization Ratio|Debt to Book Value Apyx Medical Corp APYX|ICCM (IceCure Medical, Ltd.) - Debts to Book Capitalization|LUNG - Debts to Book Value|Debts to Book Capitalization telabio.com|CytoSorbents Corporation (CTSO) - Debt to Book Value Ratio|SRTS: Debts to Book Capitalization|Debts to Net Assets Zynex Medical|Debts to Book Capitalization ECOR (electroCore, Inc.)|Debt to Book Value vicarioussurgical.com (RBOT)|Debts to Book Capitalization IINN (Inspira Technologies)|seastarmedical.com - Debts to Book Capitalization|IRIX - Debt to Book Capitalization Ratio|Intelligent Bio Solutions (INBS) - Debt to Book Capitalization Ratio|Debt to Book Value beyondair.net XAIR|Profusa, Inc (PFSA) - Debt to Net Assets Ratio|Debts to Book Capitalization SSKN (STRATA Skin Sciences Inc.)|Debts to Book Value GCTK|NAOV: Debt to Book Capitalization Ratio|Debt to Net Assets Venus Concept Inc VERO|Debt to Book Value NUWE (CHF Solutions)|Debts to Book Capitalization Aethlon Medical Corp AEMD|Debts to Book Capitalization ASXC (TransEnterix)|AVGR: Debts to Net Assets|Debt to Book Capitalization Ratio Biosig Technologies (BSGM)|CUTR (Cutera Inc.) - Debts to Book Capitalization Ratio|Debt to Book Capitalization Ratio KNW|Debt to Book Value Inari Medical Corp|Nevro Corp. - Debts to Book Capitalization|Debts to Book Value RSLS (reshapelifesciences.com)|SILK - Debt to Book Capitalization Ratio